Sandbox Reserved 474
From Proteopedia
(Difference between revisions)
Line 7: | Line 7: | ||
<StructureSection load='1gnh' size='500' side='right' caption='Structure of Human C-Reactive Protein (PDB entry [[1gnh]])' scene=''>'''C-Reactive Protein''' (CRP) is considered to be a normal plasma protein such that its concentration rises as a cytokine-mediated response resulting from tissue injury, infection or inflammation [1]. It's unique structure puts it in the pentraxin family which includes serum amyloid P component (SAP) and it consists of five identical, non-covalently associated protomers that are arranged in a symmetrical fashion weighing ~ 23kDa [1]. Since it's structure is highly conserved, the calcium dependent binding site allows found within CRP allows for strong binding to phosphocholine (PC) along with other structures and this makes it physiologically relevant. Some recent studies have made a prognostic comparison with increased CRP levels and coronary heart disease, thus reinforcing the idea that CRP also plays a significant role as a future therapeutic target [1]. | <StructureSection load='1gnh' size='500' side='right' caption='Structure of Human C-Reactive Protein (PDB entry [[1gnh]])' scene=''>'''C-Reactive Protein''' (CRP) is considered to be a normal plasma protein such that its concentration rises as a cytokine-mediated response resulting from tissue injury, infection or inflammation [1]. It's unique structure puts it in the pentraxin family which includes serum amyloid P component (SAP) and it consists of five identical, non-covalently associated protomers that are arranged in a symmetrical fashion weighing ~ 23kDa [1]. Since it's structure is highly conserved, the calcium dependent binding site allows found within CRP allows for strong binding to phosphocholine (PC) along with other structures and this makes it physiologically relevant. Some recent studies have made a prognostic comparison with increased CRP levels and coronary heart disease, thus reinforcing the idea that CRP also plays a significant role as a future therapeutic target [1]. | ||
- | |||
- | Typically, after After an acute inflammatory stimulus, CRP is synthesized by hepatocytes. CRP sits on the short arm of chromosome 1 (in humans) and it contains only one intron and it is regulated at the transcriptional level by '''cytokine interleukin-6''' (IL-6) and by '''interleukin-1β''' (IL-1β). Both IL-6 and IL-1β control expression of many acute phase protein genes through activation of several transcription factors including STAT3, C/EBP family members and Rel proteins (NF-κB). | ||
- | |||
- | Some of the biological effects/functions of CRP include: CRP's unique ability to only bind to phosphocholine ligands of either damaged or apoptotic cells. Additionally, CRP can bind to other ligands such as phosphoethanolamine, chromatin, histones, fibronectin, small nuclear ribonucleoproteins, laminin, and polycations. CRP also contains pleiotropic effects which produce both pro and anti-inflammatory responses. | ||
== Structure and Function == | == Structure and Function == | ||
CRPs five promoter structures are folded into two anti-parallel β-sheets with flattened jellyroll topologies. Each promoter contains a recognition face with a phosphocholine binding site consisting of two coordinated calcium ions adjacent to a hydrophobic pocket. | CRPs five promoter structures are folded into two anti-parallel β-sheets with flattened jellyroll topologies. Each promoter contains a recognition face with a phosphocholine binding site consisting of two coordinated calcium ions adjacent to a hydrophobic pocket. | ||
The co-crystallized structure of CRP with phosphocholine suggest that Phe-66 and Glu-81 are two key residues that mediate binding between phosphocholine and CRP. More specifically, Phe-66 provides hydrophobic interactions with the methyl groups of phosphocholine. Similarly, Glu-81 is found on the opposite end of the pocket where it interacts well with the positively charged choline nitrogen. Present on the opposite face of the pentamer is the effector face, where the presumed C1q and Fcγ receptors bind | The co-crystallized structure of CRP with phosphocholine suggest that Phe-66 and Glu-81 are two key residues that mediate binding between phosphocholine and CRP. More specifically, Phe-66 provides hydrophobic interactions with the methyl groups of phosphocholine. Similarly, Glu-81 is found on the opposite end of the pocket where it interacts well with the positively charged choline nitrogen. Present on the opposite face of the pentamer is the effector face, where the presumed C1q and Fcγ receptors bind | ||
+ | |||
+ | Typically, after After an acute inflammatory stimulus, CRP is synthesized by hepatocytes. CRP sits on the short arm of chromosome 1 (in humans) and it contains only one intron and it is regulated at the transcriptional level by '''cytokine interleukin-6''' (IL-6) and by '''interleukin-1β''' (IL-1β). Both IL-6 and IL-1β control expression of many acute phase protein genes through activation of several transcription factors including STAT3, C/EBP family members and Rel proteins (NF-κB). | ||
+ | |||
+ | Some of the biological effects/functions of CRP include: CRP's unique ability to only bind to phosphocholine ligands of either damaged or apoptotic cells. Additionally, CRP can bind to other ligands such as phosphoethanolamine, chromatin, histones, fibronectin, small nuclear ribonucleoproteins, laminin, and polycations. CRP also contains pleiotropic effects which produce both pro and anti-inflammatory responses. | ||
== Structure of CRP promoter == | == Structure of CRP promoter == |
Revision as of 22:24, 2 May 2012
This Sandbox is Reserved from 13/03/2012, through 01/06/2012 for use in the course "Proteins and Molecular Mechanisms" taught by Robert B. Rose at the North Carolina State University, Raleigh, NC USA. This reservation includes Sandbox Reserved 451 through Sandbox Reserved 500. | ||||||||||||
To get started:
More help: Help:Editing For more help, look at this link: http://www.proteopedia.org/wiki/index.php/Help:Getting_Started_in_Proteopedia
C-Reactive Protein
|